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INTRODUCTION 
 Patients with burn injuries are highly susceptible for infection as a 
result of disruption of the normal skin barrier and accompanying 
depression of immune response. 
The burn surface contains a large amount of necrotic tissue and 
the protein rich wound exudates provides a rich growth medium. So, 
following the initial period of shock, infection is the major complication 
and about 75% of the mortality associated with burn injuries is related to 
infection. In addition, overcrowding in Burns Unit is an important cause 
of cross-infection which necessitates a periodic monitoring of bacterial 
species and their antibiogram. The organisms are mainly derived from 
the patients gastro intestinal and upper respiratory tracts as well as from 
the hospital environment. 1, 2 
It is crucial for every burn institution to determine the specific 
pattern of burn wound microbial colonization, the time-related changes 
in the dominant flora, and the antimicrobial sensitivity profiles. This 
would enable early treatment of imminent septic episodes with proper 
empirical systemic antibiotics, without waiting for culture results, thus 
improving the overall infection-related morbidity and mortality. 
Individual organisms are brought into the burns ward in the 
wounds of new patient. These organisms persists as dominant flora in 
the burn treatment unit until new organisms are introduced. So 
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periodical study of the microbial profile and antibiogram is necessary. 
 Infection, the risk of which is proportional to the extent of injury, 
continues to be the predominant determinant of outcome in thermally 
injured patients despite improvements in overall care in general and 
wound care in particular. The control of invasive burn wound infection 
through the use of effective topical chemotherapy, prompt surgical 
excision, and timely closure of the burn wound has resulted in 
unsurpassed survival rates. Even so, infection remains the most 
common cause of death in these severely injured patients. 
 Alterations in the protocols of burn wound management and the 
introduction of new topical and systemic antimicrobial agents eventually 
influence the nature of the microbial flora of the ward 3 
 Most of the infections are thought to be of nosocomial origin 
wherein hand and clothing of attending staff has been implicated in 
many cases. In specialized units of the hospital with high infection rates, 
the infective agents vary with time and is unique to different hospitals.  
 In India where burns usually occur in the lower socioeconomic 
strata and in a productive age group-rational antibiotic therapy 
according to the prevalent strains of organisms should help in reducing 
the mortality and morbidity associated with burns. The analysis of the 
isolates and their sensitivity patterns helps to formulate an institutional 
drug policy for the patients admitted in Burn Unit.  
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REVIEW OF LITERATURE 
 Improvements in burn care originated in specialized units 
specifically dedicated to the care of burned patients. The interactive 
multidisciplinary team has proven to be the least expensive and most 
efficient method of treating major burn injury, of which the initial acute 
care is only a small part of the total treatment. Burn patients often 
require years of supervised rehabilitation, reconstruction, and 
psychosocial support. Omission of any step in the treatment regimen by 
any of the burn team members, including the burn surgeon, nurses, 
therapists, nutritionists, or psychosocial support staff, can result in less 
than optimal outcomes. 
EPIDEMIOLOGY 
 A study conducted in United States says that approximately 1.1 
million individuals annually are burned seriously enough to seen health 
care; about 45,000 die. More than 90% of burns are preventable; nearly 
one half are smoking related or due to substance abuse4,5. 
 The burn size associated with a 50% mortality rate has increased 
from 30% of the total body surface area (TBSA) to greater than 80% 
TBSA in otherwise healthy young adults6,7. The quality of burn care is 
no longer measured only by survival, but also by long-term function and 
appearance. Although small burns are not usually life threatening, they 
need the same attention as larger burns to achieve optimal outcomes. 
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 As with other forms of trauma, burns frequently affect children 
and young adults. In children under 8 years of age, the most common 
burns are scalds, usually from the spilling of hot liquids8. In older 
children and adults, the most common burns are flame-related, usually 
the result of house fires, the ill-advised use of flammable liquids as 
accelerants, or smoking-or alcohol-related9. Chemicals or hot liquids, 
followed by electricity, and then molten or hot metals most often cause 
work-related burns10. 
ETIOLOGY OF BURN INJURY 
SCALD BURNS 
 Scalds, usually from hot water, are the most common cause of 
burns in civilian practice. Water at 140°F (60°C) creates a deep partial-
thickness or full-thickness burn in 3 seconds. At 156°F (69°C), the same 
burn occurs in 1 second11. Exposed areas of skin tend to be burned less 
deeply than clothed areas, as the clothing retains the heat and keeps 
the hot liquid in contact with the skin for a longer period of time. 
Immersion scalds are always deep, severe burns12. 
FLAME BURNS 
 Flame burns are the second most common mechanism of thermal 
injury. Smoking-related fires, improper use of flammable liquids, motor 
vehicle collisions, and ignition of clothing by stoves or space heaters 
also are responsible for flame burns. 
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FLASH BURNS 
 Flash burns are next in frequency. Explosions of natural gas, 
propane, butane, petroleum distillates, alcohols, and other combustible 
liquids, as well as electrical areas cause intense heat for a brief time 
period13,14. At least some areas of flash burns often heal without 
requiring extensive skin grafting, but the burns generally cover a large 
TBSA, and in an explosive environment may be associated with 
significant thermal damage to the upper airway. 
CONTACT BURNS 
 Contact burns result from contact with hot metals, plastic, glass, 
or hot coals. They are usually limited in extent, but are invariably deep.  
It is common for patients involved in industrial accidents to have 
associated crush injuries because these accidents are commonly 
caused by contact with presses or other hot, heavy objects15. Motor 
vehicle and motorcycle collisions may leave victims in contact with hot 
engine parts16. The exhaust pipes of motorcycles cause a characteristic 
burn of the medial lower leg, that although small, usually requires 
excision and grafting.        
Causes 
Flame Damage from superheated, oxidized air 
Scald Damage from contact with hot liquids 
Contacts Damage from contact with hot or cold solid materials 
Chemicals Contact with noxious chemicals 
Electricity Conduction of electrical current through tissues 
                                                                                                                                
 12
BURN DEPTH 
 The depth of burn varies depending on the degree of tissue 
damage. Burn depth is classified into degree of injury in the epidermis, 
dermis, subcutaneous fat, and underlying structures. 
Depths 
First degree Injury localized to the epidermis 
Superficial second degree Injury to the epidermis and superficial dermis 
Deep second degree Injury through the epidermis and deep into the 
dermis 
Third degree Full-thickness injury through the epidermis and 
dermis into the subcutaneous fat. 
Fourth degree Injury through the skin and subcutaneous fat 
into underlying muscle or bone 
 
BURN SIZE 
Determination of burn size estimates the extent of injury. Burn 
size is generally assessed by the “rule of nines”. In adults, each upper 
extremity and the head and neck are 9% of the TBSA., the lower 
extremities and the anterior and posterior trunk are 18% each, and the 
perineum and genitalia are assumed to be 1% of the TBSA.  Children 
have a relatively larger portion of the body surface area in the head and 
neck, which is compensated for by a relatively smaller surface area in 
the lower extremities. Infants have 21% of the TBSA in the head and 
neck and 13% in each leg, which incrementally approaches the adult 
proportions with increasing age. 
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Body surface area diagram. This figure depicts the relative 
percentage of the total body surface area of defined anatomic areas 
 
It would seem likely that the larger the burn wound, the more 
likely it would be contaminated and colonized with microorganisms. In a 
prospective study of 53 pediatric patients with burns in which the data 
were analyzed by multivariate analysis, Fleming and coworkers showed 
a significant relationship between colonization of burn wounds with 
microorganisms from patients fecal flora and the size of their burn 
wounds17. Again, it is likely that risk factors for colonization also place 
the burn wound at greater risk for infection. 
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Berkow Digram to Estimate Burn Size Based on Area of Burn  
in an Isolated Body Part in Percentage. 
Area 0-1yr 1-4yr 5-9yr 10-14yr 15-18yr adult 
Head 19 17 13 11 9 7 
Neck 2 2 2 2 2 2 
Anterior trunk 13 13 13 13 13 13 
Posterior trunk 13 13 13 13 13 13 
Right buttock 2.5 2.5 2.5 2.5 2.5 2.5 
Left buttock 2.5 2.5 2.5 2.5 2.5 2.5 
Genitalia 1 1 1 1 1 1 
Rt upper arm 4 4 4 4 4 4 
Lt upper arm 4 4 4 4 4 4 
Rt lower arm 3 3 3 3 3 3 
Lt lower arm 3 3 3 3 3 3 
Rt hand  2.5 2.5 2.5 2.5 2.5 2.5 
Lt hand 2.5 2.5 2.5 2.5 2.5 2.5 
Rt thigh 5.5 6.5 8 8.5 9 9.5 
Lt thigh 5.5 6.5 8 8.5 9 9.5 
Rt leg 5 5 5.5 6 6.5 7 
Lt leg 5 5 5.5 6 6.5 7 
Rt foot 3.5 3.5 3.5 3.5 3.5 3.5 
Lt foot 3.5 3.5 3.5 3.5 3.5 3.5 
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In a retrospective study in which data were analyzed by multiple 
regression analysis, Merrell and colleagues found a significant 
relationship between burn wound size and subsequent occurrence of 
fatal sepsis18. Fifty-four percent of the fatalities were due to burn shock. 
Graves and associates also observed a significant relationship between 
burn wound size and infection in a retrospective study19. 
BURN PREVENTION 
More than 90% of all burns are preventable, and ongoing 
prevention and education efforts seem to be the most effective means 
to impact burn incidence. Using flame-resistant sleepwear for children, 
smoke detectors, required in all residential rental units and new 
construction, have likely contributed to decreased burn severity and 
mortality20. 
BURN CENTER REFERRAL CRITERIA 
1. Partial-thickness and full-thickness burns totaling greater than 
10% TBSA in patients under 10 or over 50 years of age. 
2. Partial-thickness and full-thickness burns totaling greater than 
20% TBSA in other age groups. 
3. Partial-thickness and full-thickness burns involving the face, 
hands, feet, genitalia, perineum, or major joints. 
4. Full-thickness burns greater than 5% TBSA in any age group. 
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5. Electrical burns, including lightning injury. 
6. Chemical burns. 
7. Inhalation injury. 
8. Burn injury in patients with preexisting medical disorders that 
could complicate management, prolong the recovery period, or 
affect mortality. 
9. Any burn with concomitant trauma (e.g., fractures) in which the 
burn injury poses the greatest risk of morbidity or mortality. If 
the trauma poses the greater immediate risk, the patient may 
be treated initially in a trauma center until stable, before being 
transferred to a burn center. The physician’s decision should 
be made with the regional medical control plan and triage 
protocols in mind. 
10. Burn injury in children admitted to a hospital without qualified 
personnel or equipment for pediatric care. 
11. Burn injury in patients requiring special social, emotional, 
and/or long-term rehabilitative support, including cases 
involving suspected child abuse. 
ETIOLOGY OF BURN WOUND INFECTION 
 Both the nature of the burn wound and microorganism-specific 
factors influence the rate of microbial proliferation in and penetration of 
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the burn eschar. Burn tissue, rich in coagulated protein and well 
hydrated by the trans-eschar movement of fluid and serum creates an 
excellent microbial culture medium. The eschar is avascular owing to 
thermal thrombosis of nutrient vessels, limiting both the delivery of 
systemically administered antibiotics and the migration of phagocytic 
cells into the burned tissue. Bacterial proliferation in the wound may 
also be enhanced by such factors as wound maceration, pressure 
necrosis, and wound desiccation with neo-eschar formation. In addition, 
secondary impairment of blood flow to the wound may further 
predispose the patient to invasive infection by curtailing the delivery of 
oxygen, nutrients, and phagocytic cells to the viable subeschar tissue. 
 Without the application of topical antimicrobial agents, the density 
of bacteria grows progressively, and the microorganisms penetrate the 
eschar by migration along sweat glands and hair follicles until the 
eschar nonviable tissue interface is reached. Further microbial 
proliferation occurs in the subeschar space, enhancing the lysis of 
denatured collagen and sloughing of the eschar. If the density and 
invasiveness of the microorganisms exceed the defense capacity of the 
host, proliferating organisms in the subeschar space may invade the 
underlining viable tissue, leading to invasive burn wound infection and 
even systemic spread to remote tissues and organs. 
 Certain strain-specific factors also appear to be important in the 
pathogenesis of invasive burn wound infection. The production of 
enzymes, such collagenase, elastase, protease, and lipase, may 
enhance the organisms ability to penetrate the eschar. Moreover, 
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bacterial motility and antibiotic resistance appears to be  important in 
the development of invasive infection. Effective topical antimicrobial 
chemotherapy limits intraeschar bacterial proliferation and the attendant 
risk of invasive infection. 
HOST IMMUNE FUNCTION 
 Thermal injury initiates a deleterious pathophysiologic response in 
every organ system, with the extent and duration of organ dysfunction 
proportionate to the size of the burn. Direct cellular damage is 
manifested by coagulation necrosis, with the depth of tissue destruction 
determined by the duration of contact and the temperature to which the 
tissue is exposed. Following burn, the normal skin barrier to microbial 
penetration is lost, and the moist, protein-rich avascular eschar of the 
burn wound provides an excellent culture medium for microorganisms. 
While destruction of the mechanical barrier of the skin contributes to the 
increased susceptibility to infection, postburn alterations in immune 
function may also be of significant importance. Every component of the 
humoral and cellular limbs of the immune system appears to be affected 
after thermal injury; the magnitude and duration of dysfunction are 
proportional to the extent of injury. 
Alterations in lymphocyte subpopulations, including reversal of 
the normal ratio of T-helper cells to T-suppressor cells, have been 
described21,22. Delayed hypersensitivity reactions and peripheral blood 
lymphocyte proliferation in the mixed lymphocyte reaction are both 
inhibited following burns. Alterations in interleukin-2 (IL-2) production 
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and IL-2 receptor expression by lymphocytes have been observed with 
burn injury; a direct correlation has been established between the extent 
of the burn and the decline of IL-2 production by peripheral 
lymphocytes23. 
 Increased numbers of circulating B lymphocytes are evident early 
in the postburn course; however, serum immunoglobulin G (IgG) levels 
decline after burn injury and gradually return to normal over the 
succeeding 2 to 4 weeks. The association of higher numbers of 
circulating B cells but reduced serum levels of IgG suggests a defect in 
the ability of B cells to generate a normal response after burn injury24. 
Similar findings have been observed in IgM producing cells isolated 
from murine mesenteric lymph nodes and spleens following burns25. 
Exogenous administration of IgG to burn patients has been shown to 
promptly restore IgG levels to normal but exerts no demonstrable effect 
on the incidence or outcome of infections26. 
RISK FACTORS FOR INFECTION 
 The extent of burn injury (i.e., TBSA) is one of the major 
determinants of overall outcome, and the incidence of infection 
correlates with burn severity.27 Children appear to be more susceptible 
to systemic infection than adults for any given size burn.28 However, 
burns involving less than 20% TBSA in otherwise healthy individuals are 
rarely associated with life-threatening infection. The presence of an 
inhalation injury strongly correlates with infection, particularly 
pneumonia. Premorbid diabetes significantly increases infection rates 
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following thermal injury, especially when coupled with poor glycemic 
control29 . 
In addition to the risk of infection associated with the wound itself, 
catheters and other invasive devices increase risk30. The use of silver-
impregnated devices, including central lines and Foley catheters, may 
reduce catheter-related infection risk. Other causes of morbidity and 
mortality in patients with burn injuries are inhalation injuries and 
pneumonia. 
CLINICAL MANIFESTATIONS AND DIAGNOSIS 
CLINICAL SIGNS OF BURN WOUND INFECTION 
1 Focal dark brown or black discoloration of wound 
2 Conversion of second degree burn to full-thickness necrosis 
3 Degeneration of wound with neo-eschar formation 
4 Unexpectedly rapid eschar separation 
5 Hemorrhagic discoloration of subeschar fat 
6 Violaceous or erythematous edematous wound margin 
7 Metastatic septic lesions in unburned skin or distant organs 
Many of the physiologic criteria defining sepsis are noninfectious 
sequelae of postinjury hypermetabolism. Hyperthermia, tachyeardia, 
increased ventilation, and high cardiac output, indicative of sepsis as 
well as a hyperdynamic-hypermetabolic state, are part of the normal 
response to major burns in otherwise healthy patients. 
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Body temperature regulation is altered in burn patients, and is 
partially dependent upon environmental conditions. Hyperthermia 
(>38.5°C) is routinely present following thermal injury, particularly in 
children, and is a poor indicator of infection.31,32 Conversely, 
hypothermia commonly heralds sepsis, usually due to gram-negative 
organisms. Leukocytosis in the burn patient is also nonspecific. As long 
as large wounds remain open, variable elevations in leukocyte counts 
are common. Thrombocytosis is invariable following major thermal 
injury, whereas thrombocytopenia is a fairly reliable manitestation of 
sepsis.  
WOUND INFECTION 
All burn wounds become colonized by 72 hours after injury with 
the patient’s own flora or with endemic organisms from the treatment 
facility. Bacteria colonize the surface of the wound and may penetrate 
the avascular eschar. 
By definition, burn wound invasion, is a histologic diagnosis 
where microscopic evidence of invasion of non-burned tissue with 
bacteria is present and bacteremia imminent. Unfortunately, burn 
wound biopsies are expensive, invasive because a section of unburned 
tissue needs to be included with the biopsy, and associated with 
considerable variability between adjacent sites of the burn wound33. 
These facts together with more aggressive wound debridement, newer 
topical antimicrobials, and improved nutritional support and intensive 
care have limited the use of burn wound biopsy in many burn centers34. 
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 Swab cultures are helpful to identify potential pathogens 
colonizing the wound, and they provide valuable information to guide 
prophylactic perioperative systemic antibiotic selection for wound 
debridement. Whereas for anaerobic cultures exudates, swabs from 
burns, wounds and skin abscesses are generally unaceeptable for 
anaerobic cultures52. 
 Types of bacteria that colonize and infect burn patients and their 
antibiotic sensitivity are highly variable between burn units and highly 
influenced by topical antimicrobials and wound care policies as well as 
systemic antibiotic use. Revathi et al. described their experience in 600 
burn patients with infections35 which was similar to many burn units 
where the most common and severe infections were caused by 
Pseudomonas  spp., than Staphylococcus aureus followed by other 
gram negative organisms that include Klebsiella spp., Acinetobacter 
spp., Escherichia coli, Enterococcus faecalis, Proteus spp., and others.  
A recent comparison between two, 10-year periods of gram negative 
isolates in pediatric burn patients showed that in the 1990s, Ps. 
aeruginosa accounted for 35.2% of gram negative organisms from 
infection sites compared to 33.6% in the 1980s. Recently, Acinetobacter 
spp., replaced Klebsiella spp., as the second most common bacteria 
causing infections in pediatric burn patients36. In a recent overview of 
wound isolates in United Kingdom burn centers, an increasingly 
prevalent Acinetobacter has been reported37. 
 Serious infections caused by Pseudomonas  aeruginosa remain a 
common complication in thermally injured patients contributing 
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substantially to burn morbidity and mortality.  In a survey of 176 burn 
care centers in North America; Pseudomonas   species was considered 
the most serious cause of the life threatening infections in the thermally 
injured patients38. Similarly, in 1985 a 25 year review of Pseudomonas  
bacteremia in burn patients by McManus et al. documented an overall 
burn mortality of 77%  with Ps. aeruginosa bacteremia that was 28% 
above predicted39. Despite advancements in medical and surgical care 
of burn patients, no significant improvement in mortality was 
documented over the 25-year period in which burn patients cared for in 
their institution39.  
 Ps. aeruginosa  is an opportunistic gram-negative pathogen 
which produces many exoproducts including elastase, alkaline 
protease, hemolysin, exotoxin A, exoenzyme S and together with its 
heterogeneous lipopolysaccharide mediate much of its virulence40. 
Pseudomonas  organisms possess flagellum rendering it motile, a 
morphologic feature considered important in virulence in burn patients41. 
However, adherence of the bacterium to both biologic cell membranes 
and inert surfaces is mediated through pili or fimbriae and by the 
production of large amounts of exopolysaccharides which are strongly 
anionic linear chains of β-D-mannuronic and α-1-guluronic acids that 
bind water and form gels42. This alginate or slime production mediates 
adhesion in the mucoid non-motile form of Pseudomonas , where 
together with specific ion binding proteins such as the iron binding 
siderophores, pyochelin and pyoveridin, it can extract iron and other 
nutrients from its environment and thrive in microcolonies40. The 
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production of alginate and many cell surface enzymes including 
penicillinases makes the organism very difficult to treat or eradicate and 
predisposes the burn wounds and medical equipment and devices in 
burn units to Pseudomonas   infection and contamination. 
 The gram negative bacteria including Klebsiella, E. coli and 
Acinetobacter as well as Pseudomonas  are the major causes of 
mortality in burn center. McManus et al. in 1985 suggested that 10% of 
all burn patients develop Pseudomonas  bacteremia which carries a 
mortality rate of 80%39,43 and the risk of Pseudomonas  infection 
increases substantially in burns>30%. Both for cystic fibrosis and burns, 
Pseudomonas  morbidity and mortality can be significantly reduced by 
measures taken to avoid nosocomial infection or to delay the onset of 
infection as long as possible44. Avoidance of nosocomial Pseudomonas  
infections is likely of major significance not for the small superficial of 
clean wound in younger patients where the risk of mortality is low, but in 
larger or deeper wounds or in hosts with increasing age, inhalation of 
other risk factors which put them at risk of death from burn injury 
particularly if they become infected early in their course with an 
antibiotic resistant gram negative organisms such as Pseudomonas 45. 
 A prospective study was carried out on 70 burned patients 
admitted to the Burn Unit, Ain Shams University Hospital, Cairo, with 
the aim to verify the pattern of microbial colonization of burn wounds. 
Throughout the study period starting from 1 June 1999 till 31 May 2001, 
281 sampling procedures (surface swabs) were performed from the 
burn wounds. A total of 301 microbial isolates were grown in cultures, 
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Eight different species of bacteria, and only one species of Candida (C. 
albicans) were detected. There was no incidence of recovery of 
anaecrobic microorganisms. Their results revealed that the most 
frequent isolate was Ps. aeruginosa (21.6%), followed by Klebsiella 
pneumoniae (15.2%), then Escherichia coli (13.6%), Staphylococcus 
aureus (13.2%), coagulase-negative Staphylococci (11.6%) 
Streptococcus pyogenes (8.3%) Enterobacter species (6.6%), and lastly 
Streptococcus faecalis and Candida albicans (5.9 and 3.6%, 
respectively). Studying the time-related changes in burn wound 
microbial colonization showed an initial predominance of gram-positive 
cocci upon admission (70.7%) over gram-negative bacilli 27.6%46. 
During the first 5 days gram-negative bacilli started to predominate 
(55.7%) over gram positive cocci (40.3%). Burn wound sampling 
performed starting from the sixth day onwards revealed further 
prevalence of gram negative bacilli (72.7%) over gram positive cocci 
(22.7%) 
 In specialized units of the hospital with high infection rates, the 
spectrum of infective agents varies with time and is unique to different 
hospitals. Acinetobacter spp. are rapidly emerging as an important 
pathogens predominantly in many units such as intensive care units, 
burn units and surgical wards across the globe including India47-50. 
Emergence of Acinetobacter spp. with the added problem of fast 
emerging multiple resistance is becoming a serious therapeutic problem 
as increased mortality has been reported48. The increase of multi-drug 
resistant extended spectrum beta-lactamase (ESBL) producing strains 
among the clinical isolates has further limited the therapeutic options50. 
It is therefore necessary to carry out periodic reviews of patterns of 
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isolation and susceptibility profiles of microorganisms infecting burn 
wounds in order to modify the preventive and therapeutic strategies. 
 A retrospective study of major aerobic bacterial isolates from 
pus/wound swabs taken from patients admitted to the burn unit at Govt. 
Medical Collage Hospital, Chandigarh, India, over a period of 5 years 
(June 1997-May 2002) was undertaken. The study was carried out to 
determine the bacterial profile and antimicrobial susceptibility of the 
isolates and to describe the change in trends over the study period. The 
pus/wound swabs yielded very high culture positivity (96%) for 665 total 
isolates. Pseudomonas  aeruginosa was found to be most common 
isolate (59%) followed by Staphylococcus aureus (17.9%). 
Acinetobacter spp. (7.2%), Klebsiella spp. (3.9%), Enterobacter spp. 
(3.9%), Proteus spp. (3.3%) and others (4.8%). Although Ps. 
aeruginosa continued to remain the predominant isolate over the five 
years, a constant and significant increase in the incidence of 
Acinetobacter spp. was found. Amikacin was found to be the most 
effective drug against gram negative bacteria, however, resistance to it 
was significantly increased over 5 years. For S. aureus and Ps. 
aeruginosa netilmicin and piperacillin were found to be the most 
effective drugs. Most of the isolates showed high level resistance to 
antimicrobial agents51. 
Nasser et.al (2003) study revealed coagulase-negative 
Staphylococci were recovered at a frequency of 11.6%. this relatively 
low incidence is consistent with many previous reports on burn wound 
colonization in which the pathogenicity of this organism has been 
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questioned. Vindenes et.al study revealed higher rates of recovery of 
CONS in the wound of burned patients. In view of the 
immunocompromise status of critically-ill burned patients, such centers 
have consistently stressed that CONS should be considered a 
significant pathogen. 
Liedberg et al., emphasized septicaemia as a common cause of 
death55. 
Tumbusch et al., reported that more alarming upsurge in 
septicaemia due to gram negative bacteria. This has been 
predominantly due to Pseudomonas  aeruginosa but occasionally 
Klebsiella & Escherichia 56. 
Rosen F. S. points out that destruction of large number of 
bacteria with release of endotoxin probably occurs in the burns wound 
and in other sites of infection. The circulating bacterial endotoxin may 
be responsible for the severe physiological disturbance of 
Pseudomonas  septicaemia in addition to irreversible shock severe 
leucopenia and profound hypothermia or hyperpyrexia are consistent 
effects of lethal doses of endotoxins in a variety of species57. 
PREVENTION OF BURN WOUND INFECTION 
Progress in the general care of the critically burned patient has 
included a significant emphasis on the prevention of infectious 
complications. These efforts have focused mainly on the areas of 
environmental control (through single-bed rooms and other forms of 
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isolation) and topical antimicrobial prophylaxis of the burn wound. 
Effective infection control programs are essential to reducing the 
exposure of patients in critical care units to nosocomial pathogens. 
Such control includes strictly enforced hand washing, gowning, and 
gloving policies. When new endemic microbial strains are identified, 
increased efforts to prevent patient-to-patient spread and unit 
environmental contamination may be accomplished using cohort patient 
care techniques. Cohort care, which entails the assignment of patient 
care personnel in teams to provide care for only a specific patient or 
only patients colonized or infected with a targeted organism limits the 
spread of, and can even eliminate, antibiotic-resistant endemic 
organisms58. 
Effective infection control programme for burn centers should 
include scheduled microbial surveillance of colonization of patients, 
environmental hygiene monitoring procedures, biopsy assessment of 
the microbial status of the burn wound as necessary, monitoring of the 
incidence and causes of infection, and timely review of culture and 
clinical data by an infection control committee. 
Early removal of devitalized tissue prevents wound infections and 
decreased inflammation associated with the wound. In addition, it 
eliminates small-colonized foci, which are a frequent source of transient 
bacteremia. 
Topical and systemic antimicrobial therapy has significantly 
diminished the incidence of invasive burn wound sepsis. Perioperative 
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antibiotics clearly benefit patients with injuries greater than 30% TBSA 
burns. 
BURN WOUND HYGIENE AND TOPICAL ANTIMICROBIAL 
THERAPY 
Care of the burn wound begins at the accident scene by covering 
the wounds with clean sheets or blankets to preserve body temperature 
and prevent continued environmental exposure. The burns are gently 
cleansed with a surgical detergent disinfectant, and nonviable epidermis 
is debrided. Bullae should be excised and body hair shaved from the 
area of thermal injury beyond the margin of normal skin. The patient is 
placed in a clean bed, and bulky dressings may be positioned beneath 
the burned parts to absorb the often copious serous exudates. These 
dressings should be changed when they become saturated or soiled 
and patients should be turned frequently to prevent maceration of 
burned and unburned skin. 
Burn injury treatment includes the use of both systemic and 
topical therapies, in addition to wound debridement, immune support, 
and proper nutrition.59. Systemic antibiotics are administered to prevent 
development of infection; however, if sepsis occurs, antibiotics are 
continued until 72 hours after the infection has been eradicated60. 
Topical antimicrobial agents are used to prevent microbial growth within 
the burn wound. 
The three agents with proven broad-specturm antimicrobial 
activity when applied to the burn wound are silver sulfadiazine (SSD), 
mafenide acetate, and silver nitrate. SSD is the most common agent 
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used in burn centers and has antifungal properties in addition to good 
bacterial coverage61. However, SSD does not penetrate eschar. Only 
mafenide acetate is able to penetrate eschar, and it is the only agent 
capable of suppressing dense subeschar bacterial proliferation. The 
main disadvantage of mafenide acetate is its carbonic anhydrase 
inhibition, which may interfere with renal buffering mechanisms. 
Bicarbonate is consumed, chloride is retained, and the resulting 
hyperchloremic metabolic acidosis is compensated for by an increase in 
ventilation and subsequent respiratory alkalosis. However, this is 
typically of little clinical consequence. Silver nitrate must be used before 
bacteria have penetrated the wound. Its disadvantages are the 
associated electrolyte imbalances (e.g., hyponatremia). 
Topical antimicrobial creams are usually used with closed 
dressings. This provides for greater patient comfort and less dessication 
than the open technique. The creams are spread on fine meshgauze, 
applied on the wounds, then covered with bulky protective gauze 
dressing and an elastic compressive wrap. 
HEPARIN SALINE DRESSING 
Heparin, a highly sulfated glycosoaminoglycan was studied 
originally of its anticoagulant property has been dealt in new prospective 
as an anti-inflammatory agent62. Nevertheless that heparin facilitates 
wound healing and shortens the recovery period in thermal burns was 
established already in guinea pigs and in clinical trials with human 
burns62,63. 
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Heparin is postulated to play a positive role in angiogenesis or 
neovascularization and this process of formation of new blood vessels 
is an important step in wound healing. Heparin is proposed to be an anti 
inflammatory agent64. 
The pathogenesis of trauma in burns and the role of pro-
inflammatory and inflammatory modulators in sepsis and trauma remain 
unclear. A better understanding of the modulation of interleukin-6 
expression will enable us to develop more appropriate therapy for burn 
injury65. 
Efficacy of standard heparin on superficial partial thickness and 
deep partial thickness burn injury of 15 patients was assessed and 
compared with 15 control patients. Based on Total Burn Surface Area 
(TBSA), 15 patients were categorized into 3 groups and the modulation 
of serum interleukin-6 levels were assessed and compared with 
untreated control. Significant differences in cytokine IL-6 levels (p<0.05) 
were observed in heparin treated patients compared with untreated 
burn patients. There was significant variations in serum IL-6 on the day 
of admission and post burn day 10 in treated as well as untreated burn 
patients. Patients with higher percentage of total body surface area 
showed significant increase in IL-6 in the serum. The histochemical 
studies of the biopsy samples revealed that heparin treatment 
accelerated healing and reduced the time for remodeling. Clinical 
assessment of healing showed good correlation with histochemical and 
biochemical results. The administered heparin accelerated wound 
healing in burn patients66. 
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The inflammation increase in size with swelling or edema in the 
local burn area of control groups and heparin treated burn patient 
swelling did not appear, or when it was present it subsided and did not 
reappear. Heparin treated burns in humans67-73. became progressively 
smaller in size was observed in the guinea pigs62. 
The beneficial effects were evident in thermal burns of humans 
when Saliba & Griner used large dose of heparin administrated both 
parenterally and topically62,74. Bacterial translocation [BT] continues to 
be a serious problem after severe burn, and is an important cause of 
mortality and morbidity103. Bacterial translocation is one of the most 
important causes of sepsis after severe burn injury104. Research in 
many experimental burn models has demonstrated that heparin 
increases survival and decreases BT105,106; however, it is still not known 
how heparin reduces BT, that is, which mechanism is responsible for 
these effects64. Recent work has demonstrated that heparin exerts anti-
inflammatory effects on burns in humans and animals by inhibiting C1 
esterase, an important enzyme in the complement cascade system79,80. 
This inhibitory action of heparin can be considered an 
immunosuppressive agent27.49   
BIOLOGICAL DRESSING  
All topical antimicrobial agents adversely affect wound healing, 
alter metabolic rate, and require re-application and daily maintenance. 
Biological dressing have no direct toxins of antimicrobial properties. 
However, they create a wound environment that prevents dessication, 
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diminishes bacterial proliferation, reduces loss of heat, water, protein 
and red blood cells, and promotes more rapid wound healing. Biological 
dressings also reduce burn wound pain61. 
These coverings include allograft (cadaver skin), xenograft (pig 
skin), Transcyte, Biobrane, and Integra. These should generally be 
applied within 24 hours of the burn injury, before high bacterial 
colonization of the wound occurs. Most often, synthetic and biological 
dressings are used to cover second-degree wounds while the 
underlying epithelium heals or it is used to cover full-thickness wounds 
for which autograft is not yet available. Each type of dressing has its 
advantages and disadvantages. 
Biobrane consists of silicone and collagen manufactured into a 
sheet. This is placed on the wound and becomes adherent in 24 to 48 
hours with dried exudates. This sheet then provides a barrier to 
moisture loss, and it provides a relatively painless wound bed that does 
not require dressing changes75. 
Biobrane should be used primarily in superficial second degree 
burn and split-thickness skin graft donor sites. 
On the basis of work carried out in Lazovic G et al (2005)53., the 
following properties of collagen sheet are summarized. 
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Biological 
• Collagen sheet is non-inflammatory 
• Collagen sheet facilitates migration of fibro-blasts and 
microvascular cells 
• Collagen sheet helps in the synthesis of neodermal collagen 
matrices 
• Collagen sheet has low antigencity 
• Collagen sheet has minimal biodegradation 
• Collagen sheet is non - toxic 
• Collagen sheet helps in minimizing scarring 
Physiological 
• Collagen sheet is impermeable to bacterial migration 
• Collagen sheet modulates fluid flux from the wound 
• Collagen sheet is elastic, soft, and supple 
• Collagen sheet has good tear strength 
• Collagen sheet has good suturing characteristics 
• Collagen sheet has enough strength to be peeled off the 
wound 
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Adverse Effects 
 Collagen sheet has been found to be well tolerated in clinical 
trials. There have been no reports of clinically significant immunological 
or histological responses to the implementation of collagen sheet, and 
no reports of rejection of collagen sheet. 
EXCISION AND GRAFTING 
Deep second and third-degree burns do not heal in a timely 
fashion without autografting. In fact, the practice of leaving these dead 
tissues only serves as a nidus for inflammation and infection that could 
lead to the patient’s death. Early excision and grafting of these wounds 
is currently done by most burn surgeons since reports have shown 
benefit over serial debridement in terms of survival, blood loss, and 
length of hospitalization.76,77,78. 
After a burn wound has been excised, the wound must be 
covered. This covering is ideally the patient’s own skin. Wounds 
covering 20 to 30% TBSA can usually be closed at one operation with 
autograft split-thickness skin taken from the patient’s available donor 
sites. In these operations, the skin grafts are not meshed, or they are 
meshed with a narrow ratio (2:1 or less), to maximize cosmetic 
outcome. 
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AIMS OF THE STUDY 
• To study the profile of aerobic bacteria in patients with 20-40% 
burns. 
• To identify the factors that influence the outcome in these patients. 
• To determine the type of dressing that contributed to better outcome. 
• To study the antibiogram pattern  of bacteria in the burns unit.     
• To   determine the prevalence of β lactamase producing strains.                               
• To study the factors that contribute to prevention of infection and 
mortality in these patients. 
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MATERIALS AND METHODS 
PLACE OF STUDY 
 This is a cross sectional study done involving 100 patients both 
male and female admitted to the Burn Unit, Department of Plastic and 
Reconstructive Surgery, Kilpauk Medical College and Hospital, 
Chennai. The study was carried  out  at the Institute of Microbiology, 
Madras Medical College, Chennai. 
PERIOD OF STUDY 
 July 2005 to January 2006  
STUDY GROUP 
 100 patients both male and female of age group 1  year to 65 
years with burns of total body surface area (TBSA) of 20 to 40% were 
included in the study. These patients had burns ranging from deep 
partial thickness to full thickness injury. All patients received Tetanus 
toxoid booster upon admission.  
SPECIMENS 
1 Wound swabs from burn area. 
2 Swabs from intact skin in the nasal, axillary, inguinal and 
umbilical regions of the patients. [If the skin in the above areas 
was burned samples were considered as burn wounds] 
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3 Blood from peripheral vein. 
4 Environmental sampling study 
COLLECTION & TRANSPORT OF SPECIMENS 
Sterile cotton swabs were prepared using non-absorbent cotton 
wool, (Rabbo and Benjamin 1951) swab sticks were introduced into 
test tubes and plugged and were sterilized in the hot air oven at 160°C 
for 1 hour. 
Wound Swab 
Swabs were taken at the time of admission, 3rd or 4th day and 7th 
or 8th day. Swabs were taken from clinically deep areas of burn wound 
after cleansing. 
 Swabs from nasal, axillary, inguinal and umbilical regions were 
taken on the day of admission to study about the endogenous source of 
organisms. Swabs moistened in sterile saline were used to obtain nasal 
and skin samples. 
BLOOD 
 Blood was obtained by aseptic venipuncture. For venipuncture, 
skin over the selected area for blood sampling is prepared by first 
cleaning with 70% alcohol and then with 2% Povidone Iodine. The 
disinfectant agent was allowed to act for 1 minute. In case of adults, 
about 5ml was collected. In case of infants and children only 3ml was 
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collected. Blood was directly inoculated into 50ml of Brain Heart 
Infusion broth. 
ENVIRONMENTAL SAMPLES 
 Environmental sampling study was carried out from inanimate 
environment and the nursing staffs to find out the source of infection. 
 Swabs premoistened with normal saline were taken from the 
various sources of the environment & subjected to aerobic culture and 
other standard procedure for isolation and identification of microbial 
organisms. 
 The following were included as sampling sites.  
1) Walls & Floors  
2) McIntosh sheet 
3) Linen 
4) Cot 
5) Dressing trolleys 
6) Dressing Bin 
7) Gloves 
8) Antiseptic solutions  
9) Tap water  
10)Ward attender  (male) I&II – nasal, throat and hand swabs  
11)Ward attender (female)  I&II – nasal, throat and hand swabs 
12)Washing Room 
13)Bath Room 
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 Air contamination was studied by Blood agar settle plate method. 
A blood agar plate was kept near the ICU, male & female wards 
exposed for the duration of one hour. The plates were incubated and 
subjected to standard bacteriological studies. 
 The samples were transported immediately to the laboratory and 
processed. 
MICROBIOLOGICAL ANALYSIS 
DIRECT GRAM STAIN 
 Direct Gram stain smear of all the samples were done  
CULTURE 
 Specimens were cultured on Nutrient agar, 5% sheep Blood agar 
and MacConkey’s agar plates. Incubation was done at 37° C for 24-48 
hours. The plates were examined for the growth at 24 hours. If growth 
was observed colony morphology and gram stain morphology were 
studied. If no growth was observed, the plates were further incubated 
for the next 48 hours. Blood agar was used to identify the gram positive 
cocci along with their haemolytic properties. MacConkey’s agar was 
used to identify gram negative organisms, mainly the lactose fermenters 
& non-lactose fermenters. The bacterial isolates were then identified by 
means of Gram staining, motility and various biochemical reactions like 
Catalase, Oxidase, Indole, Citrate, Urease, Slide and Tube Coagulase, 
Triple sugar iron agar, Phenylalanine deaminase, Modified Hugh and 
Leifsons O/F test, Mannitol motility, Nitrate reduction, Methyl red, 
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Voges-proskauer, fermentation of sugars like Glucose, Sucrose, 
Lactose, Maltose, Mannitol, Mannose by standard microbiological 
techniques as recommended by NCCLS guidelines. 
 To perform the above Biochemical reactions the following media 
were used. 
1. Peptone water. 
2. Sugars-Glucose, Lactose, Maltose, Mannitol and Sucrose. 
3. Glucose phosphate broth  
4. Simmons citrate medium. 
5. Christensen’s urea agar. 
6. Triple Sugar Iron Agar medium.  
PROCESSING OF BLOOD   
Brian heart infusion broth was used as the primary culture 
medium for blood and subcultures were  made onto BAP, MAC and NA 
plate after 48 hours or on signs of growth like turbidity, lysis, pellicle and 
clot formation. The plates were examined for growth. The colony was 
then identified by Gram stain and various biochemical reactions and 
tested for its susceptibility to various antimicrobial agents. Subculture 
were made every third day for a period of 10 days and negative report 
was given if there was no growth. 
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PROCESSING OF SWABS – NASAL, AXILLARY, INGUINAL AND 
UMBILICUS 
 The swabs were inoculated onto Blood Agar Plate and 
MacConkey’s Agar Plate and incubated at 37°C aerobically. The 
presence of growth was observed at 24 hours and 48 hours. If growth 
was present colonies were isolated and identification of the organism 
was done as described earlier. 
DETECTION OF ANTIMICROBIAL SUSCEPTIBILITY PATTERNS 
 Antimicrobial susceptibility pattern was done on Mueller-Hinton 
agar by Kirby-Bauer Disc diffusion method as recommended by 
NCCLS. 
Test inoculum-0.5 Mc Farland lawn culture. 
Incubation-37°C for 16-18 hrs in ambient air. 
Control strains: 
   Staph aureus-ATCC 25923. 
   E. coli-ATCC-25922. 
   Pseudomonas  aeroginosa-ATCC 27853. 
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The antibiotics used [Discs were procured from Himedia] 
Inhibition zone in mm 
Antimicrobial Agent 
Resistant Intermediate Sensitive 
PenicillinG (10 U) <20 21-29 >30 
Ampicillin(10 mg) <20 21-29 >30 
Oxacillin(I mcg)   >13 
Gentamicin(10 mcg) >12 13-14 >15 
Amikacin(30 mcg) >14 15-16 >17 
Ciprofloxacin(5 mcg) >15 16-20 >21 
Ofloxacin(5 mcg) >12 13-15 >16 
Cefotaxime ( 30mcg) 
Gm+ve<14 
Gm-ve<10 
15-22 
11-15 
>23 
>16 
Ceftazidime(30 mcg) 14 15-17 >18 
Imipenem (10mcg) <13 14-15 >16 
Vancomycin(30 mcg)   >15 
 
The diameters of the zones of inhibition were interpreted 
according to NCCLS standards for each organism. 
IDENTIFICATION OF BETA-LACTMASE PRODUCTION: 
The determination of beta-lactamases production was done by 
iodometric method.  
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PROCEDURE 
IODOMETRIC METHOD 
REQUIREMENTS 
i) 1% soluble starch solution prepared by dissolving the 
starch at 100°C 
ii) Iodine reagent consisting of 2.03g iodine and 5.32 g 
potassium iodide in 100 ml distilled water. 
iii) Microtitre plate. 
PROCEDURE         
  From an overnight incubation culture of the test organism, a 
heavy suspension was made (containing 109 CFU/ml) in 100mM sodium 
phosphate buffer at pH7.3 containing penicillin at 6g/litre, along with 
positive and negative controls. 
Positive control – E. coli ATCC 35218. 
Negative control – E. coli ATCC 25922. 
The test and the control organisms were inoculated into the wells 
of a microtitre plate. After incubation for 1 hr at 37°C, two drops of 
freshly prepared 1 % soluble starch solution were added to each well. A 
drop of iodine reagent was then added. If blue colour was lost within 10 
minutes, the presence of beta lactamase was inferred. If, however, the 
blue persisted, the culture was considered to be beta-lactame-negative. 
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DETECTION OF EXTENDED-SPCTRUM BETA-LACTAMASES 
(ESBL) 
ESBLs are enzymes that meditate resistance to extended-
spectrum (third generation) cephalosporins (e.g., ceftazidime, 
cefotaxime, and ceftriaxone) and monobactams (e.g., aztreonam) but 
do not affect cephamycins (e.g., cefoxitin). 
 Cefpodoxime and ceftazidime have been proposed as indicators 
of ESBL production. 
METHODS ADOPTED FOR DETECTION 
 Isolates showing a zone of inhibition<22 mm for ceftazidime were 
tested for ESBL production as per NCCLS criteria, using standard 
control strains. 
1. COMBINED DISC METHOD 
 Latest guidelines by NCCLS recommend a combined disc method 
as an indicator of ESBL production. For disc diffusion testing, ≥5 mm 
increase in zone diameter of the antimicrobial agent tested in 
combination with betalactamase inhibitor (e.g., clavulanic acid, 
sulbactam) versus its zone when tested alone confirms an ESBL 
producing organism. 
 Combined Disc method using cefaperazone (75 mcg) and 
cefaperazone-sulbactam (75 mcg/30 mcg) was performed for 
phenotypic confirmation of ESBL production. 
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2. DOUBLE DISC SYNERGY TEST 
 In this test a lawn of the test strain on Mueller Hinton agar was 
exposed to discs of ceftazidime (30 mcg) and augmentin (20 mcg 
amoxycillin/10 mcg clavulanic acid) arranged in pairs. The discs were 
arranged so that the distance between them is approximately twice the 
radius of the inhibition zone produced by the cephalosporin tested on its 
own. After overnight incubation, the test strain was an ESBL producer if 
the inhibition zone around the cephalosporin disc was extended on the 
side nearest the augmentin disc. 
SCREENING FOR Amp-C AND ESBL PRODUCING ISOLATES 
USING MODIFIED DOUBLE DISK SYNERGY TEST107 
           Isolates with zone of inhibition <22 mm for ceftazidime were 
tested. A 0.5 McFarland turbidity of test isolate was swabbed on Mueller 
Hinton agar plates and disk of ceftazidime (30µg) was placed adjacent 
to clavulanic acid in (10 µg) and cefoxitin (30µg) disc was placed at a 
distance of 20 mm from each other. After incubation an enhanced zone 
of inhibition between ceftazidime and clavulanic acid were interpreted 
as presumptive evidence for the presence of ESBL. 
 Isolates that showed reduced susceptibilty ceftazidime and 
cefoxitin were considered as screen positive and selected for detection 
of Amp C b-lactamases. 
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CONFIRMATORY TEST FOR Amp C BETA LACTAMASES  
Amp C DISC TEST 
  A lawn culture of E.coli ATCC 25922 was prepared on MHA 
plate. Sterile discs (6mm) were moistened with sterile saline(20µl) and 
inoculated with several colonies of test organism. The inoculated disc 
was then placed on the inoculated plate beside a cefoxitin disc almost 
touching it. The plates were incubated overnight at 35ºC .A positive test 
appeared as flattening or indentation of the cefoxitin inhibition zone in 
the vicinity of the test disc. A negative test had an undistorted zone. 
MINIMUM INHIBITORY CONCENTRATION (MIC) 
 MIC was done for the drug cefotaxime by agar dilution method for 
Gram negative bacilli. 
PROCEDURE 
MEDIA 
19 ml of Mueller-Hinton agar is prepared in tubes, autoclaved and 
allowed to cool in a 50°C water bath. 
ANTIBIOTIC 
i) Cefotaxime was dissolved in sterile water. Then serial dilutions of 
the antibiotic from 1mg/l to 256mg/l were then made. One ml of 
the antibiotic solution was added to 19 ml of MHA and poured into 
the petri dish. A control plate containing the test medium without 
the antibiotic is prepared for each series of the dilution. After the 
plates have set, they were dried at 37°C for 20 minutes in the 
incubator. 
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TEST INOCULUM 
 The test strains were inoculated in peptone water and its turbidity 
adjusted to 0.5 McFarland standard to get a working inoculum of 10 
CFU/ml. A multipoint micropipette was used to deliver 2 μl so that the 
final inoculum on the agar surface would be 10 CFU/spot. 
CONTROLS 
 Standard control strains were used in every batch of MIC tests. 
ENVIRONMENTAL STUDY 
1. Swabs premoistened with normal saline taken from various 
parts were processed using standard microbiological methods 
as described earlier. 
2. Water sampling108 - 100ml of water was inoculated into equal 
volume of double strength MacConkey broth and inoculated at 
37°C for 48 hours. Then subculturing was done on Blood Agar 
Plate, MacConkey’s Agar Plate and processed using the 
standard microbiological methods. 
3. Air contamination was looked for in the intensive care unit, 
male and female wards. This was done by exposing Blood 
Agar Plate for duration of 1 hour. The plates were incubated at 
37°C aerobically for 24 hours and then processed. The colony 
count was done and the bacteria was identified as described 
earlier. The antibiogram was done for the bacteria isolated 
from the environmental study.   
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RESULTS  
Table 1: INCIDENCE OF AGE AND SEX IN THE BURNS CASES 
Age Group In 
Years Male Female Total 
1-10 6 3 9 
11-20 8 14 22 
21-30 14 22 36 
31-40 13 10 23 
41-50 1 4 5 
51-60 - 1 1 
61-70 2 2 4 
Total 44 56 100 
 
Young females were found to be most commonly affected.(11-40yrs) Of 
the 9 Paediatric patients 6 were less then 6 years old. 
 
Table 2: CAUSES OF BURNS 
Children Adults 
  
Male Female Male Female 
Flame  81 - - 35 46 
Scald 17 6 3 3 5 
Electrical 2 - - 2 - 
 
Flame was the most common cause (81%) in this study followed by 
scalds. The electrical injury was the least common cause and observed 
in 2 cases. Scald injuries were observed more commonly in children 
and women. 
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Table: 3.  PERCENTAGE OF BURNS IN RELATION TO AGE & SEX 
20 – 30 % 31 – 40 % 
 
Male Female 
Total 
Male Female 
Total 
0-12 4 2 6 2 1 3 
13-35 21 26 47 11 19 30 
36-60 4 4 8 - 2 2 
>60 2 1 3 - 1 1 
Total 31 33 64 13 23 36 
 
Among 100 patients 64 cases presented with 20-30% Burns. More no. 
of 20-30%  burns have been observed in young adults. 
 
 
Table 4: MORTALITY RATE IN RELATION TO AGE 
Ages In Years Total 100 Mortality 41 Percentage 41% 
Children     0-12 9 2 22.2% 
Adults      13-35 77 32 41.5% 
36-60 10 6 60% 
>60 4 1 25% 
Total Adults 91 39 42.85% 
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Table 5:  
CORRELATION OF MORTALITY WITH DEGREE OF BURNS 
 
Mixed II° 
Superficial 
No: 20 
II°  
Deep 
No: 27 
III° 
No: 3 
 
I&II° 
No: 28 
II&III° 
No: 22 
 
No % No % No % No % No % 
Survival 18  21  -  15  5  
Death 2 10 6 22 3 100 13 46 17 77 
Total 20  27  3  28  22  
 
A higher mortality rate was observed in patients with III° and II°&III° 
mixed burns. 
Table 6 
MORTALITY AND SURVIVAL IN TERMS OF TIME DURATION 
 < 1 week 1-2 weeks 
2-3 
weeks 
3-4 
weeks 
> 4  
weeks 
No. of death  
 41 
32 
(78%) 
4 
(9.75%) 
2 
(4.87%)
2 
(4.87%) 
1 
(2.43%) 
No. of discharges 
among survivors 
59 
26 
(44.06%) 
18 
(30.50%)
3 
(5.08%)
7 
(11.86%) 
5 
(8.47%) 
 
Highest percentage of mortality occurred within the first week. Among 
the survivors most were discharged within the first 2 weeks of 
hospitalization. 
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Table 7: CORRELATION BETWEEN MORTALITY AND 
PERCENTAGE OF BURNS 
Children   No: 9 Adults   No: 91 
Male Female Male Female % of 
Burns 
No. Of 
Patients 
Death No. Of 
Patients Death 
No. Of 
Patients Death 
No. Of 
Patients Death 
20-30% 4 - 2 - 27 
5 
19% 
31 
8 
26% 
31-40% 2 
1 
50% 
1 
1 
100% 
11 
6 
54% 
22 
20 
91% 
Total 6 1 3 1 38 11 53 28 
 
The mortality of females with 31-40% of Total Burn Surface Area was 
the highest. 
 
Table: 8  DEPTH OF BURN & TYPE OF DRESSING 
Type Of Dressing 
Collagen Heparin Saline SSD 
 
Children Adult
s 
Children Adults Children Adults 
II° Superficial 4 3 - 13 - - 
II° Deep 2 3 - 22 - - 
III° - - - 2 - 1 
Mixed 
I& II 
II&III 
 
3 
- 
 
9 
- 
 
- 
- 
 
14 
18 
 
- 
- 
 
2 
4 
Total 9 15 - 69 - 7 
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Heparin saline dressing was commonly applied followed by collagen 
dressing. In children only collagen dressing was applied. 
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Table: 9:  TYPE OF DRESSING AND MORTALITY 
Collagen 
Total 24 
Heparin Saline 
Total 69 
SSD 
Total 7  
No % No % No % 
Survival 18 75 38 55 3 43 
Death 6 25 31 45 4 57 
 
Mortality was reported more in dressings with Silver Sulpha Diazine 
followed by Heparin saline. Collagen dressing had the best outcome. 
 
Table: 10 MORTALITY IN TERMS OF TIME DURATION IN 
INHALATION INJURY 
Death Patients with  
inhalation injury No of Cases % 
8 
(9.8%) 8 100% 
 
Among  81 flame injury patients  8  patients had inhalation injury. 100% 
mortality occurred in burns with inhalation injury. 
 
Table 11: SOURCE OF INFECTION - ENDOGENOUS 
Organisms 
Nose 
Swabs  
No. 73 
Axillae 
Swabs  
No. 82 
Umbilicus 
Swabs  
No. 67 
Groins 
Swabs  
No. 84 
CONS 14 10 3  
S. aureus 7  1  
Micrococci  17 10 6 
Diphtheroids  8 10 7 
E.coli    5 
Klebsiella spp.     13 
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Table 12: SOURCE OF INFECTION - EXOGENOUS 
Inanimate 
ICU, Male & Female Wards  
Ward 
Attenders 
Organisms 
Floor 
and 
Walls 
Linen Cot Trolley Blood Agar 
settle plate 
 
Ps. aeruginosa 2 2 1 1 3  
Acinetobacter  spp 3 2  1 3  
E. coli 1      
Klebsiella spp  4   3  
Diphtheroids 2     2 
S. aureus     1 2 
CONS      4 
 
37 isolates were obtained from hospital environment & staffs  
 
Table: 13 PATHOGENIC ORGANISMS ISOLATED 
 
Day 1 
I Swab 
No: 100 
% 
Day 3&4 
II Swab 
No: 94 
% 
Day 7 
III Swab 
No: 43 
% 
No Of Swabs 100  94  43  
No Growth 66 66% - - - - 
Monomicrobial 30 30% 42 44.6% 11 25.5% 
Polymicrobial 4 4% 52 55.31% 32 74.41%
 
On admission polymicrobial type of infection was less and it was more 
with the patients who stayed in the hospital for longer days. 
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Table: 14 PATHOGENIC ORGANISMS ISOLATED IN WOUND 
SWABS 
Organisms Isolated 
I Swab  
No.100 
Organisms  
No. 38 
II Swab  
No. 94 
Organisms 
No. 166 
III Swab  
No. 43 
Organisms 
No. 89 
Monomicrobial 30 42 11 
Pseudomonas  aeruginosa 7 20 6 
Klebsiella spp 4 13 3 
Acinetobacter spp 2 1  
Escherichia coli  4  
CONS 12   
Staphylococcus aureus 5 4 2 
Polymicrobial 4 52 32 
Pseudomonas + Acinetobacter  6 8 
Pseudomonas + Escherichia coli  3  
Acinetobacter+ Klebsiella  11 3 
Klebsiella+ CONS 2   
Pseudomonas + Klebsiella  12 7 
Pseudomonas + CONS 2   
Pseudomonas + Acinetobacter+ 
Klebsiella  11 8 
Pseudomonas + Acinetobacter+ 
S. aureus  5 4 
Pseudomonas + S. aureus+ 
Klebsiella  4 2 
 
The initial swabs were predominantly monomicrobial with gram positive 
isolates and which is replaced by gram negative isolates in the later 
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swabs, which were also polymicrobial 
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Table 15 BACTERIAL ISOLATES AT VARIOUS LEVELS 
 
I SWAB (100) - ORGANISMS No. 38 II SWAB (94) - ORGANISMS No. 166 III SWAB (43) - ORGANISMS No. 89 
Single Mixed Total Single Mixed Total Single Mixed Total ORGANISMS 
NO % NO % NO % NO % NO % NO % NO % NO % NO % 
Gram negative 
bacilli 
  44.64   92.16   91.02 
Pseudomonas 
aeruginosa 
7 18.42 2 5.26 9 23.68 20 12.04 41 24.69 61 36.73 6 6.74 29 32.58 35 39.32 
Klebsiella spp 4 10.52 2 5.26 6 15.78 13 7.83 38 22.89 51 30.72 3 3.37 20 22.47 23 25.84 
Acinetobacter spp 2 5.26     2 5.26 1 0.6 33 19.87 34 20.47   23 25.84 23 25.84 
Escherichia coli -           4 2.4 3 1.8 7 4.2       
Gram positive 
cocci 
  55.25   7.82  8.98 
Staphylococcus 
aureus 
5 13.15     5 13.15 4 2.4 9 5.42 13 7.82 2 2.24 6 6.74 8 8.98 
CONS 12 31.57 4 10.52 16 42.1                   
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Table: 16   PATHOGENIC ORGANISMS 
ORGANISMS TOTAL   No:293 PERCENTAGE 
Pseudomonas  
aeruginosa 105 35.84 
Klebsiella spp 80 27.30 
Acinetobacter spp 59 20.13 
Escherichia coli 7 2.38 
Staphylococcus aureus 26 8.87 
CONS 16 5.46 
 
Pseudomonas  aeruginosa was the commonest organism isolated. 
Gram Positive cocci found only 14.33% of the total isolates. 
 
Table: 17 BLOOD CULTURE REPORT 
 Positive Cultures 
Negative  
Cultures 
Total No. Of Blood Cultures 94 21 (22.34%) 73 (77.65%) 
No. Of Survivors 2 (9.6%) 51 (69.86%) 
No. Of Death 19 (90.4%) 22 (30.13%) 
 
The mortality among  blood culture negative patients could have been 
due to other factors, or due to commencement of antibiotic therapy. 
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Table: 18 PATHOGENIC ORGANISMS ISOLATED FROM  
BLOOD CULTURE 
 Ps. aeruginosa Acinetobacter Klebsiella 
Blood Culture 
positive with 
Death No:19 
18 
(94.7%) 
 
1 
(100%) 
Blood Culture 
positive with 
Survival No:2 
1 1  
 
All 21 organisms isolated from the Blood culture were similar to the 
organisms isolated from the wound swabs. 
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Table :19   ANTIBIOTIC SENSITIVITY PATTERN OF GRAM NEGATIVE BACILLI 
organisms No. of 
Organisms 
Ciprofloxa
cin Ofloxacin Amikacin Gentamycin Ampicillin 
Cefo -
taxime 
Cefta- 
zidime 
Cefa- 
perazone 
Cefaperazone 
Sulbactam 
Imipenem 
Pseudomonas 
aeruginosa 
105 
 
64 
61% 
70 
67% 
82 
78% 
78 
74% 
62 
59% 
78 
74% 
82 
78% 
87 
83% 
105 
100% 
105 
100% 
Klebsiella spp 80 
 
69 
86% 
54 
68% 
59 
74% 
52 
65% 
60 
75% 
66 
83% 
66 
83% 
68 
85% 
80 
100% 
80 
100% 
Acinetobacter spp 59 
 
43 
73% 
40 
68% 
52 
88% 
33 
56% 
43 
73% 
30 
51% 
46 
78% 
49 
83% 
59 
100% 
59 
100% 
Escherichia coli 7 
 
3 
43% 
2 
29% 
3 
43% 
2 
29% 
3 
43% 
2 
29% 
2 
29% 
4 
57% 
7 
100% 
7 
100% 
 
 
Table: 20 ANTIBIOTIC SENSITIVITY PATTERN OF GRAM POSITIVE COCCI 
 
Organisms 
No. of 
Organisms Penicillin Ampicillin Cloxacillin Oxacillin Ofloxacin Ceftazidime Cefotaxime Gentamicin Vancomycin 
S. aureus 26 6 
23% 
12 
46% 
13 
50% 
18 
69% 
21 
81% 
20 
77% 
20 
77% 
12 
46% 
26 
100% 
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CONS 16 
 
8 
50% 
6 
38% 
10 
63% 
12 
75% 
11 
69% 
12 
75% 
13 
81% 
7 
44% 
16 
100% 
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Table: 21    β – LACTAMASE PRODUCTION 
Organisms No of  β lactamase  
producers 
Percentage 
S. aureus   No: 26 16 62% 
CONS  No: 16 9 56% 
 
 
Table: 22  ESBL PRODUCERS 
 Organisms No of ESBL 
producers 
Percentage 
E coli  (7) 4 57.14% 
Klebsiella spp (80) 11 13.75% 
Ps. aeruginosa (105) 10 9.52% 
 
Ceftazidime resistant isolates – E.coli  (5),  Klebsiella (14)  and   
Ps.aeruginosa (23)  were tested  for ESBL production. 
 
 
Table: 23  MIC OF CEFOTAXIME FOR GRAM 
NEGATIVE ISOLATES 
 
Organisms 16 mg/l 64 mg/l 125 mg/l 250 mg/l >250 mg/l 
P. aeruginosa  - 27  4 2 9 12 
Klebsiella spp  - 14 4 3 3  4 
E coli  - 5  2  2 1 
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4  Klebsiella  isolates  showed    intermediate     sensitivity  to  cefotaxime   on 
 
Kirby-Bauer disc  diffusion method. 
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DISCUSSION 
Burns provide a suitable site for bacterial multiplication and 
infection, mainly because of the larger area involved and longer 
duration of patient stay in the hospital. To ensure early and appropriate 
therapy in burn patients, a frequent evaluation of the wound is 
necessary. Therefore, a continuous surveillance of microorganisms and 
a regular update of their antibiotic resistance pattern is essential to 
maintain good infection control programmes in the burn unit, thus 
improving the overall infection-related morbidity and mortality. 
The age and gender distribution [table 1] shows that the incidence 
was more in young adults between 11 – 40 years of age. Jayaraman 
et.al83 study showed 58.9% of burns occurred in young adults between 
11-30 years of age.  Males exceeded females upto 10 years of age. 
Burn occurred more frequently in young females belonging to the age 
group of 13-35 years out of 56 total females (80.35%) [table 3].  This 
may be due to clothing catching fire while cooking on a floor level 
kerosene stove84. This study corresponds with the study made by V. 
Jayaraman et.al (1993)83. In their study the incidence of females were 
55.8% and the females belonging to age group of 13-36 years had 
higher incidence. 
The most common cause of injury (table 2) was flame 81%. 
Scalds come next to flame burns. Herndon et.al(2001)8 stated in 
children the most common burns are scalds. In our study scald injuries 
were observed more commonly in children and women [table 2]. This 
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study corresponds with other studies of Jayaraman et.al (1993)84 
(26.8%) and Vaishnav at.al (1974)85 29%. In our study electrical burns 
were few 2%, Steven E. Wolf86 quoted 3 to 5% of all admitted patients 
of injured from electrical contact. 
 In this study patients with burns of 20-40% were included. More 
than 40% and less then 20% were not studied since patients with more 
than 40% burns had been observed to have a high mortality rate and 
most of the burns of less than 20% healed without infection.  Jayaraman 
et.al., in their work on Epidemiology of Burn injury quoted the possibility 
of survival was present only in patients having burn less than 50% Total 
Burn Surface Area.                         
Table 3 shows 64% were between the range of 20-30% and only 
36% were between the range of 31-40%. 
 The total mortality rate was 41% and the mortality rate for children 
was 22.2%  and 42.85% for adults (table 4). Jayaraman et.al reported 
40.6% of total mortality rate. Among the total no. of deaths, more deaths 
occurred in females [table 7]. This corresponds to the study of Mathangi 
et.al90 who had stated 67% of total no. of patients who had died were 
females between 13-35 years of age. In this study 78% of the death 
occurred within a week's time and 9.75% of death occurred in the 2nd 
week (table 6). Mathangi et.al reported 91% of death occurred within 
5days. Among the 9 children, death occurred in 2 children. The 
percentage of burns in these 2 children were between 31-40% (table 7). 
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 Heparin saline dressing was most commonly applied 69%  
(table 8). Next commonly used dressing was collagen dressing 24%. 
Collagen dressing was applied in both children and adults. For children 
only collagen dressing was applied.Collagen dressing was used only for 
II° superficial & deep and  I & II° mixed burns. For III° burns and II & III° 
mixed burns closed dressing with heparin saline /SSD were applied. 
(table 8) The mortality rate is more in patients with Silver Sulpha 
Diazine 57% and heparin saline dressing 45%.(table 9) 
 Jayaraman et.al stated 28% of patients had inhalation injury. In 
our study 9.8% of patients had inhalation injury(table 10). Schwartz81 
stated the presence of inhalation injury strongly correlates with infection 
and Wolf et.al82 stated inhalation injury increases the mortality rate. In 
our study mortality rate with smoke inhalation injury was 100%. Death 
occurred within 1 week time. The mortality of burn patients in burn units 
is well recognized to be related to the age of the patients (table 4) and 
the percentage of total area of burn wound27 (table 7) and the presence 
or absence of concomitant inhalation injury (table 10). Tredget et.al and 
Ryan et.al also stated the similar findings. In this study mortality is more 
with III° and II° & III° mixed burns (table 5). 
 In this study length of stay in hospital for those who survived was 
less than 1 week for 44.0%, and 30.50% were discharged on 2nd week 
(table 6).Mathangi et.al quoted 52.8% and 28% patients were 
discharged on the 1st and 2nd week respectively 
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In this study the pattern of burn wound microbial colonization was 
evaluated. The time related changes in the predominant flora was also 
evaluated throughout the patients hospital stay. Wound swabs were 
taken on different occasions (tables 13 and 14) the detailed 
bacteriological study was undertaken from 100 patients with 20-40% 
burns. 
Total no. of wound swab sampling on admission were 100 (day 1) 
and as 6 burns patients died within 4 days, II wound swab sampling 
(day 3&4) were done for 94 patients. 
III wound swab sampling were done on 7th or 8th day. 43 sampling 
were done as the total no. of death within one week were 32 and 25 
patients were discharged. 
 Nasser et.al (2003)46 study shows that on admission no mixed 
growth occurred in cultures. There was predominance of gram positive 
isolates (70.7%) and gram negative isolates accounted for 27.6%. In 
our study on admission, 55.25% were gram positive isolates and 
44.64% were gram negative isolates and  mixed growth occurred in 
4%(tables 13, 15). 
 During the first 4 days (II swab) Nasser et.al study showed the 
prevalence of gram negative isolates and less prevalence of gram 
positive isolate. In our study 94 sampling procedure were performed 
and 166 isolates were obtained (table 14). Among these total isolates 
92.16% were gram negative bacilli and only 7.82% were gram positive 
isolates (table 15) with 55.31% showing mixed growth.(table13) 
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 After 7 days 43 sampling procedures were done and mixed 
growth occurred in 74.41%, yielding 89 isolates (tables13&14). Among 
these total isolates, 91.02% were gram negative bacilli and 8.98% were 
gram positive cocci (table 15). 
 Lari et.al (2000)91 study showed a predominance of gram positive 
isolates on admission, which was replaced by gram negative isolates, 
subsequently. Various studies (Manson et.al (1992)87, Pruitt et.al 
(1984)88 Wurtz et.al (1995)89) also showed that the gram-positive 
organisms are gradually replaced by gram-negative organisms. 
 Agnihotri et.al (2004)51 in their study stated major aerobic 
bacterial isolates from wound swabs were Pseudomonas  aeruginosa 
59%, Staphylococcus aureus 17.9%, Acinetobacter species 7.2% and  
Klebsiella species 3.9%. 
In our study the predominant organisms isolated (table 16) were 
Pseudomonas  aeruginosa [35.84%], Klebsiella species [27.30%], 
Acinetobacter species [20.13%], Escherichia coli [2.38%] 
Staphylococcus aureus [8.87%] and CONS [5.46%]. 
  In this study swabs I [4%], swabs II [55.31%], swabs III 
[74.41%](Table 13) showed presence of polymicrobial infection. The 
most common combination was Pseudomonas  aeruginosa with 
Klebsiella species or Acinetobacter species or both. This finding is in 
accordance with the study of S. P. Thyagarajan and K. Mathangi 
Ramakrishnan (1987-1989)90 who also found mixed infection in burn 
cases. 
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Our findings concerning the high frequency of Pseudomonas  
aeruginosa (35.84%) (table 16) greatly coincide with many previous 
reports where this organism was held responsible for majority of burn 
wound infections.(Lari et.al (2000)91, Cremer et.al (1996)102. 
 Ozumba et.al (2000)92 study state that Klebsiella isolates were 
more predominant than Pseudomonas . But in our study Klebsiella was 
the second most frequently recovered organisms [27.30%] (table 16). 
 Various studies of Kaushik et.al (2001)47, Sengupta et.al (2001)48, 
Ananthakrishnan et.al (2002)50 had shown that Acinetobacter species 
are rapidly emerging as important pathogens predominantly in burns 
units. Our study showed Acinetobacter species (20.13%) (table 16) 
were the third predominant organisms isolated  and most of them 
isolated from mixed infections. 
 Staphylococcus aureus came fourth in the list of microbial isolates 
recovered in our study [8.87%] (table 16). This is contrary to many 
previous reports including the study of K. Mathangi et.al and S. P. 
Thyagarajan et.al and Singh et.al (2003) which indicated a much higher 
frequency of isolation of this organism.  
 Nasser et.al study revealed CONS were recovered at a frequency 
of 11.6%. Vindenes et.al93 study revealed higher rates of recovery of 
CONS in the burn wounds. In our study Coagulase Negative 
Staphylococci were recovered at a frequency of 5.46% (table 16), the 
organisms were isolated mainly from earlier wound swabs, taken on 
admission of the patients. 
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 McManus et.al43 in 1985 suggested that 10% of all burn patients 
develop Pseudomonas  bacteremia which carries a mortality rate of 
80% and the risk of Pseudomonas  infection increases substantially in 
burns more than 30%. Lari et.al91 in their study revealed the majority of 
bacteremic patients (most of them were Pseudomonas  infections.) died 
(89%) which is higher than that reported by Flick  et.al94 and Kreger 
et.al 95. 
In our study 21 patients (22.34%) developed bacteremia  
(Tables 17,18) of which 19 (90.4%) died. Among 21 patients 
Pseudomonas was isolated in 19 patients of whom 18 died (mortality 
rate of 94.7%) and bacteremia due to Klebsiella was observed in one 
patient who died, which caries mortality rate of 5.3%. One patient had 
Acinetobacter bacteremia, but responded to treatment.The mortality 
among blood culture negative patients could have been due to 
commencement of antibiotic therapy or due to other factors.  
ANTIBIOTIC SUSCEPTIBILITY PATTERN  
GRAM NEGATIVE BACILLI (Table 19) 
 
 The gram negative bacilli exhibited varying degree of sensitivity to 
the aminoglycosides from 29% to 88%, for fluroquinolones 29% to 86% 
for penicillins from 43% to 75% and to cephalosporins from 29% to 
85%. All the isolates were 100% sensitive to cefaperazone sulbactam 
and imipenem. 
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Pseudomonas aeruginosa 
Tredget et.al (2004)97 in their study states that among the third 
generation cephalosporins only ceftazidime and cefaperazone have 
been found to have anti-Pseudomonal activity with ceftazidime being 
more active. Our study showed Pseudomonas  resistance to 
ceftazidime (22%) and cefotaxime (26%).  
 Singh et.al (2003)98 revealed the incidence of Pseudomonas  
resistance to ceftazidime 62% and cefotaxime 66%. Revathi et.al in 
their study revealed Pseudomonas  resistance to ceftazidime 17% and 
cefotaxime 39%. 
 Gales et.al (2001)96 in their study stated meropenem is active in 
upto 95%  Pseudomonal isolates worldwide. But Tredget et.al states 
only 29% of isolates were susceptible to meropenem. In our study 
100% of Pseudomonal isolates were sensitive to imipenem. 
(carbapenem). 
 Revathi et.al (1998)35 study stated 27% of Pseudomonas  were 
resistant to amikacin and 47% of Pseudomonas  were resistant to 
gentamicin. Singh et.al stated 52% of Pseudomonas  were resistant to 
amikacin and 69% were resistant to gentamicin. In our study among 
Pseudomonal isolates 22% were resistant to amikacin and 26% 
resistant to gentamicin. 
 Gales et.al stated that worldwide 60% of Latin America and 85% 
Asia-Pacific strains of Pseudomonas  were sensitive to ciprofloxacin. 
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Tredget et.al stated only 54% Pseudomonas  were susceptible. In our 
study 61% of Pseudomonas  were susceptible to ciprofloxacin. 
 Gales et.al (2001) found that multi drug resistant Pseudomonas  
were 8.2%, while in our study 27% of Pseudomonas  were multi drug 
resistant. 
 Altoparlak et.al (2005)101 stated overall resistance rates of 
Pseudomonas  were imipenem 30.8%, meropenem 32.5%, ceftazidime 
72.5%, cefeperazone-sulbactam 52.5%, ofloxacin 66.7%, ciprofloxacin 
60.8%, amikacin 14.2% and gentamicin 28.3%. 
Klebsiella species 
 Revathi et.al35 and Singh et.al98 stated 78% and 84% of Klebsiella 
isolates were resistant to cefotaxime respectively. In our study 17% of 
isolates were resistant to both  cefotaxime and ceftazidime and 15% 
resistance with cefaperazone. 100% of Klebsiella isolates were 
sensitive to imipenem and cefaperazone-sulbactam. Both May et.al 
(2000)99 and Landman et.al (1999)100 have described their experience 
with an increase in multi-drug resistant Klebsiella with Cephalosporins. 
In our study 14% of multi-drug resistant  Klebsiella were isolated. 
Acinetobacter species 
 Revathi et.al and Singh et.al stated 81.8% and 94% 
Acinetobacter were resistant to cefotaxime. In our study 49% of 
Acinetobacter were resistant to cefotaxime. 100% of isolates were 
sensitive to cefaperazone-sulbactam and imipenem. Altoparlak et.al 
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stated resistant rates of Acinetobacter as follows: imipenem 33.3%, 
meropenem 33.3%, ceftazidime 66.7%, cefaperazone-sulbactam 
33.3%, ofloxacin 44.4%, ciprofloxacin 33.3%, amikacin 11.1% and 
gentamicin 22.2%. 
 Singh et.al stated 90% of Acinetobacter were multi-drug resistant 
which is much higher than the study conducted by NCCLS (National 
Committee for Clinical Laboratory Standards ) and Sengupta et.al. In 
our study 42% of Acinetobacter were multi-drug resistant, though there 
was no resistance to  cefaperazone-sulbactam and the carbapenems. 
Escherichia coli 
 43% of Escherichia coli were  sensitive to ciprofloxacin, amikacin 
and ampicillin. 29% of the isolates were sensitive to ofloxacin, 
gentamicin, cefotaxime and ceftazidime. 100% of the isolates were 
sensitive to cefaperazone-sulbactam and imipenem. 
GRAM POSITIVE COCCI 
 Staphylococcus aureus was 100% sensitive to vancomycin. This 
corresponds with Singh et.al and Revathi et.al studies. Komolafe et.al 
200354 stated 6.5% of Staphylococcus aureus was sensitive to ampicillin 
and 33.3% was sensitive to penicillin. In our study 46% was sensitive to 
ampicillin and 23% was sensitive to penicillin. Komolafe et.al 200354 
stated the following sensitivity pattern of Staphylococcus aureus-
penicillin 33.3%, ampicillin 6.5%, cloxacillin 20.4% and gentamicin 10%. 
In our study the following pattern of antibiotic sensitivity were observed-
 75
penicillin 23%, ampicillin 46%, cloxacillin 50%, gentamicin 46% and 
ceftazidime 77%. Kaushik et.al quoted 45.8%, 32.6% and 33.3% of 
Staphylococcus aureus were sensitive to cloxacillin, gentamycin and 
ceftazidime respectively.  
 This study showed the following sensitivity pattern of Coagulase 
Negative Staphylococcus-ampicillin 38.5%, cloxacillin 63%, gentamicin 
44%, penicillin 50% and vancomycin100%. Komolafe et.al showed only 
25% of CONS were susceptible to ampicillin and gentamicin, 100% of 
the CONS were resistant to penicillin and cloxacillin. 
Beta Lactamases 
 Beta lactamase production was observed in 56% of CONS and 
62% of the isolates in S.aureus(Table21). Methicillin resistant S.aureus 
was  31% . 
ESBL 
 In this study, ESBL producing strains were detected in 57.14% of  
Escherichia coli and  13.75% of Klebsiella spp .(Table 22) Though the 
methodology is not yet recommended for  Pseudomonas spp, 9.52% of 
Ps.aeruginosa isolates showed ESBL production by double disc 
method. Amp C  Beta lactamase production was not detected in this 
study. Singh et.al., in their study stated 89% of Klebsiella spp and 22% 
of Pseudomonas spp where ESBL producers.          
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MIC –Minimum Inhibitory  Concentration 
              In this study minimum inhibitory  concentration break points for 
cefotaxime  resistant  Klebsiella spp  were  between 16 mg/l to >250 
mg/l and Ps.aeruginosa  were between 64 mg/l to >250 mg/l.(Table 23) 
and E.coli were between 64mg/l to >250mg/l 
Environmental sampling 
Environmental sampling was done for the purpose of tracing the 
source of infection-endogenous (Table11) and  exogenous (Table 12). 
The pathogenic organisms isolated  from various sites  on the day of 
admission were S.aureus(7) from nose, E.coli(5) and  Klebsiella spp(13) 
from the groins. Among  the 7 nasal carriers  of S.aureus, 4 were  found 
to be methicillin resistant. 
          The organisms isolated from the environmental and hospital staff 
were   Ps.aeruginosa,   Acinetobacter spp,   E.coli,  Klebsiella spp   and  
S.aureus. None  of the isolates  showed    methicillin  resistant  
S.aureus. Environmental  samples showed growth of bacteria with 
sensitivity pattern of all the isolates  and pigment production of 
Ps.aeruginosa  similar to those of isolates recovered from  nearly  50% 
of the patients. 
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SUMMARY AND CONCLUSION 
• 100 patients with 20-40% burns admitted to a tertiary care center 
were included in the study. 
• Majority of the patients affected were 20-30 yrs of age. 
• Children formed 9% of study group. 
• There was a slight female preponderance (56%)  
• The commonest cause of burns was flame injury, followed by 
scalds. Electrical injuries were least common. 
• Patients with 20-30% of Total Burn Surface Area formed 64% of 
the study population. 
• Inhalation injuries ,third degree burns and second degree and 
third degree mixed burns had a high mortality rate. 
• Patients with collagen dressing had better outcome (75% 
survival) as compared to Heparin Saline dressing (55%) and 
Silver Sulfa Diazine (43%). 
• 22.34% patients developed bacteremia . Among these 90.4% had 
a fatal outcome. 
• Mortality rate was higher (60%) in the older age group (36-60 
yrs). 
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• Colonisation of burn wound was observed in 34% of patients on 
the day of admission itself. It was predominantly monomicrobial 
with Gram positive cocci. Subsequent swabs showed 100% 
colonisation with a shift to polymicrobial infection with Gram 
negative bacilli predominating. 
• Ps.aeruginosa was the commonest isolate (35.84%) and followed 
by Klebsiella spp (27.30%) and Acinetobacter spp   (20.13%). 
• Beta lactamase production was observed in almost 60% of all  
Gram positive cocci. Methicillin resistance was observed in 31% 
of S.aureus strains. No resistance to vancomycin was observed. 
• Among Gram negative bacilli Multi Drug Resistant (MDR) strains 
ranged from 9.3% in Klebsiella spp to 27% among Ps.aeruginosa 
,42% in Acinetobacter isolates and  60% of E.coli . 
• High degree of resistance to third generation cephalosporins with  
MIC levels more than 256 mg/l in cefotaxime was seen in 16 of  
these isolates. 
• ESBL production  was detected  in 9.52% of Ps.aeruginosa,   
13.75% of Klebsiella spp  and  80% of  E.coli.                                                       
• No metallo betalactamase activity  was detected                     
• Environmental  samples showed growth of bacteria with 
sensitivity pattern and pigment production similar to that of 
isolates from nearly 50% of the patients. 
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                 This suggests the need for surveillance of environmental 
saprophytes, monitoring  for MDR strains in the environment so as to 
identify and block the transmission of these strains to the patients. 
Measures such as the following have to be  implemented with 
appropriate supervision to evidence, that there is no break in the aseptic 
techniques. 
1.  To reduce the nosocomial infections, improved barrier nursing, 
personal hygiene and restriction of visitors should be strictly 
followed. 
2.  Discarded dressing materials should be properly disposed without 
delay. 
3.  Use of sterile disposable aprons or separate sets of autoclaved  
linen  for each dressing  should be provided.                                                         
4.  Adequate spacing of beds is necessary.                                                                
5. Periodical fumigation of all the wards of burns unit should be 
under taken. 
6.  Necessary equipments to provide respiratory support is needed in 
patients with inhalation injury.  
7. As the outcome of collagen dressing was good, patients may be 
provided with collagen dressing as per the clinical indication 
eventhough it is costly. 
8.  Routine surveillance  of the environment with rotation of 
antibiotics,  based upon the susceptibility pattern of environmental 
isolates can also reduce the incidence of nosocomial infection. 
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Table :19   Antibiotic sensitivity pattern of gram 
negative bacilli 
 
ORGANISM
S 
No. of 
Organisms 
Ciprofloxin Ofloxacin Amikacin Gentamycin Ampicillin Cefo -
taxime 
Cef
zidi
Pseudomonas 
aeruginosa 
105 
 
64 
61% 
70 
67% 
82 
78% 
78 
74% 
62 
59% 
78 
74% 
82
78
Klebsiella 80 
 
69 
86% 
54 
68% 
59 
74% 
52 
65% 
60 
75% 
66 
83% 
66
83
Acinetobacter 59 
 
43 
73% 
40 
68% 
52 
88% 
33 
56% 
43 
73% 
30 
51% 
46
78
Escherichia coli 7 
 
3 
43% 
2 
29% 
3 
43% 
2 
29% 
3 
43% 
2 
29% 
2
29
 
 
Table: 20 Antibiotic sensitivity pattern of Gram positive cocci 
 
Organisms 
No. of 
Organisms Penicillin Ampicillin Cloxacillin Oxacillin Ofloxacin Ceftazidime 
S. aureus 26 6 
23% 
12 
46% 
13 
50% 
18 
69% 
21 
81% 
20 
77% 
CONS 16 
 
8 
50% 
6 
37.5% 
10 
63% 
12 
75% 
11 
69% 
12 
75% 
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Table 15 Bacterial isolates at various levels 
 
I SWAB (100) - ORGANISMS No. 38 II SWAB (94) - ORGANISMS No. 166 
Single Mixed Total Single Mixed Total 
ORGANISMS 
NO % NO % NO % NO % NO % NO % 
Gram negative 
bacilli 
  44.64   92.16 
Pseudomonas 
aeruginosa 
7 18.42 2 5.26 9 23.61 20 12.04 41 24.69 61 36.73 
Klebsiella 4 10.52 2 5.26 6 15.78 13 7.83 38 22.89 51 30.72 
Acinetobacter 2 5.26     2 5.26 1 0.6 33 19.87 34 20.47 
Escherichia coli -           4 2.4 3 1.8 7 4.2 
Gram positive 
cocci 
  55.25   7.82 
Staphylococcus 
aureus 
5 13.15     5 13.15 4 2.4 9 5.42 13 7.82 
CONS 12 31.57 4 10.52 16 42.1             
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APPENDIX 
CULTURE MEDIA 
BRAIN HEART INFUSION BROTH  
Sodium citrate    1gm 
Sodium chloride    4gm 
Sodium phosphate   5gm 
Dextrose     10gm 
Peptone     10gm 
BRAIN HEART INFUSION 
Brain infusion broth   250ml 
Heart infusion broth    750ml 
Sodium polyanethol sulphonate 0.25gm 
Obtain Ox brain and heart. Remove all fat from the heart. Cut into 
small pieces and grind. Add distilled water three times and keep at 4°C 
overnight. 
From the brain, remove meninges fully and then, weigh. Add 
distilled water and mash by using hand. Keep in the cooler over night. 
Next morning boil the brain and heart separately for 30 minutes. 
Then filtered through cotton layer. Measure each broth separately. Mix 
both infusions and the remaining ingredients. Dissolve well and adjust 
pH of the entire amount to 7.4 to 7.6. 
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Autoclave at 121°C for 15 minutes. Filter through filter paper and 
distribute in screw-capped bottles in 50 to 100ml amounts. Autoclave 
once more at 115°C for 10 minutes. 
CHOCOLATE AGAR 
Sterile Defibrinated blood  - 10ml 
Nutrient Agar (melted)  - 100ml 
When the temperature was about 75°C, sterile blood was added 
with constant agitation. After addition of blood, kept in water bath and 
heating was continued till the blood changed to chocolate colour. 
Cooled to about 50°C and poured about 15ml into Petri dishes with 
sterile precaution. 
MACCONKEY AGAR 
Peptone   -2gm 
Sodium chloride  -2gm 
Bile salt   -0.5gm 
Lactose   -1gm 
Agar    -1.5gm 
Distilled water  -100ml 
All the ingredients except lactose were dissolved in distilled water 
by heating. pH adjusted to 7.61 ml of 1% neutral red solution was added 
to every 100ml of medium with lactose and sterilized by autoclaving at 
121° C for 15 minutes. 
 84
MEDIA FOR BIOCHEMILCAL IDENTIFICATION OF BACTERIA 
Oxidase      Catalase 
Indole     Triple Sugar Iron agar 
Citrate     Urease 
Methyl Red- Voges Proskauer  Nitrate reduction. 
Phenyl alanine deaminase test Carbohydrate Fermentation media 
1.OXIDASE REAGENT 
Tetra methyl P- phenlene diamine dihydro chloride -1% aqueous 
solution. 
2.CATALASE TEST 
3 % Hydrogen peroxide 
3. INDOLE REAGENT  
Kovac’s reagent 
Para dimethyl amino benzaldehyde -10gm 
Iso amyl alcohol -150ml 
Hydrochloric acid -80ml 
4.TRIPLE SUGAR IRON AGAR 
Sodium chloride 0.5gm 
Yeast extract 0.5gm 
Peptone 2gm 
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Agar 1.5gm 
Distilled water 100ml 
Distilled by keeping in boiling water bath and the following ingredients 
were added. 
Lactose 1.0gm 
Sucrose 1.0gm 
Dextrose 0.1gm 
Sodium thio sulphate 0.03gm 
Ferrous sulphate 0.02gm 
pH adjusted to 7.6 phenol red 0.0024gm (2.4 ml of 1% solution) was 
added and distributed into test tubes in 4ml quantities and autoclaved. 
The tubes were kept in a slanting position so that to get a deep but and 
a short slant. 
5.SIMMON’S CITRATE AGAR 
Sodium chloride 5.0g 
Magnesium sulphate 0.2g 
Ammonium dihydrogen phosphate 1.0g 
Potassium dihydrogen phosphate 1.0g 
Sodium citrate 5.0g 
Agar 20.0g 
Bromothymol blue (1/500 aqueous solution) 40ml 
Distilled water 100ml. 
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The ingredients were mixed and pH adjusted to 6.9 sterilized by 
autoclaving and poured into tubes as slopes. 
6.CHRISTENSEN’S UREA AGAR 
Urea Solution 
Sodium chloride -5.0g 
Dextrose -1.0gm 
Trypticase -1.0gm 
Mono potassium phosphate -2.0gm 
Urea -20.0gm 
Distilled water -100gm 
Phonol red 1% solution -1.2ml (in alcohol) 
UREA AGAR BASE 
Agar -1.5 gm 
Distilled water -90ml 
The ingredients were dissolved in distilled water. pH adjusted to 
6.8. Phenol red solution was added & sterilized by filtration. This is 
stock solution. 
Agar was dissolved in distilled water and sterilized by autoclaving. 
Cooled to 45 degree C and 10ml of urea solution was added, dispensed 
in 3-5ml quantities and allowed to form a small butt and a long slant. 
 
 87
7.GLUCOSE PHOSPHAT E BROTH (MR-VP medium) 
Dipotassium phosphate 5.0gm 
Glucose 5.0 gm  
Distilled water 100ml  
The above ingredients were suspended in distilled water and 
heated slightly to dissolve them sterilized at 115° C for 15 minutes. 
8. POTASSIUM NITRATE BROTH 
Potassium nitrate (KNO3)  0.2gm 
Peptone 5.0gm 
Distilled water 100ml 
The above ingredients were mixed and transferred into tubes in 
5ml amount and autoclaved. 
9. PHENYL ALANINE DEAMINASE TEST 
Yeast extract     5g 
Disodium hydrogen phosphate  1g  
Agar       12g 
Di-Phenylalanine     2g 
Sodium chloride     5g 
Distilled water     lr 
pH adjusted to 7.4, distributed in tubes and sterilized by autoclaving at 
121° C minutes, allowed to solidify as long slopes. 
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MEDIA FOR TESTING ANTIBIOTIC SENSITIVITY PATTERN  
Mueller-Hinton Agar 
Beef extract   20.0gm 
Acidicase peptone  7.5gm 
Starch    1.5gm 
Agar     17.0gm 
Distilled water   1000ml 
The ingredients were dissolved in one liter of distilled water, 
mixed thoroughly. Heated with frequent agitation and boiled for  
1 minute. pH adjusted to 7.4 +/- 0.2. sterilized by autoclaving and 
poured in plates. 
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PROFORMA 
 
Name   :    D.O.A.  : 
Age   :    D.O.D  : 
Sex   :    IP NO  : 
Occupation :    Ward No : 
Education :    Weight  : 
Marital Status :    Time of incident : 
Time of starting treatment:    
Type of burns  :     Chemical        Fire          Electrical        Scald 
Degree of the burns : 
Depth of the burns :                 Superficial      Deep 
Type of dressing   : 
Sites Affected 
Head 
Neck 
Anterior trunk 
Posterior trunk 
Right buttock 
Left buttock 
Genitalia 
Right upper arm 
Left upper arm 
Right lower arm 
Left lower arm 
Right hand 
Left hand 
Right thigh 
Left thigh 
Right leg 
Left leg 
Right foot 
Left foot 
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Microbiological investigations 
 
1. Number of swabs  I   II   III 
2. Sites of the swabs  
3. Date and Time of taking the swabs 
4. Blood Culture 
 
Culture Reports Microbiology Antibiogram 
Axillae 
Nose 
Umbilicus 
Groin 
 
  
Wound swabs 
I 
II 
III 
Blood culture 
  
 
 
Outcome Of The Patients 
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ABBREVIATONS 
NCCLS -  National Committee for Clinical Laboratory Standards. 
BAP       -  Blood Agar Plate. 
MAC       - MacConkeys Agar Plate. 
NAP       - Nutrient Agar Plate. 
MHA       - Mueller Hinton Agar. 
MIC       - Minimum Inhibitory Concentration. 
TBSA      - Total Burn Surface Area. 
SSD       - Silver Sulpha Diazine. 
CONS     - Coagulate Negative Staphylacoccus. 
GPC       - Gram Positive Cocci. 
GNB       - Gram Negative Bacilli. 
ESBL     -  Extended Spectrum Beta Lactamases. 
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